WO1996036345A1 - An anti-aids semifluid extract of traditional chinese medicines and preparation thereof - Google Patents
An anti-aids semifluid extract of traditional chinese medicines and preparation thereof Download PDFInfo
- Publication number
- WO1996036345A1 WO1996036345A1 PCT/CN1995/000069 CN9500069W WO9636345A1 WO 1996036345 A1 WO1996036345 A1 WO 1996036345A1 CN 9500069 W CN9500069 W CN 9500069W WO 9636345 A1 WO9636345 A1 WO 9636345A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- parts
- aids
- portions
- traditional chinese
- take
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/804—Rehmannia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/284—Atractylodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/34—Campanulaceae (Bellflower family)
- A61K36/344—Codonopsis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/40—Cornaceae (Dogwood family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
Definitions
- AIDS has spread to more than 160 countries and regions around the world. It is showing a clear upward trend in Asia. AIDS is an autoimmune disease mainly manifested by cellular immune deficiency caused by HIV infection, and its treatment includes: combating HIV-based virus infection and other conditional pathogen infection, regulating immune function, treating malignant diseases (such as card (Bosch's sarcoma, lymphoma) and supportive therapies. It is reported that no less than 50 new anti-AIDS drugs are currently being developed in the United States, but only azidothymidine (AZT), dideoxyinosine (DDI), dideoxythymidine (DDT) are approved for clinical use by FD A. ), Dideoxycytidine (DDC), etc.
- AZT azidothymidine
- DI dideoxyinosine
- DDT dideoxythymidine
- DDC Dideoxycytidine
- the pharmacological effects of Chinese herbal medicine and its compound preparations are reflected in the following aspects: fight against viruses and certain opportunistic infections, improve or suppress the body's immune function and its effect on immune function, and the two-way regulation mechanism.
- the traditional Chinese medicines used to treat AIDS at home and abroad are: glycyrrhizin (ie Qiangli Ning), Bawei astragalus tablets, Xiangru polysaccharides and so on. It is reported that these Chinese medicines have the effect of inhibiting the formation of HIV and the degeneration of infected cells, and have a certain effect on some AIDS.
- the purpose of the present invention is to provide a Chinese medicine preparation for AIDS patients with high efficacy, small side effects, safety and reliability, and cheap price.
- the technical scheme for the protection of Chinese medicine against AIDS is as follows:
- the basic design idea of the technical scheme of the present invention is to choose to promote the rise of CD 4 and CD 8 lymphocytes; it has two-way regulation of immune function; it can resist inflammation, anti-virus and improve
- the Chinese herbal medicine of the body's nutritional status is the raw material component. According to clinical trials, research and analysis formulate the corresponding component proportion and its production process. According to this component, weight ratio and technological process, Chinese medicine can be prepared to fight AIDS.
- the components and weight ratios of Chinese medicines against AIDS are as follows: Dangshen 12 parts, Atractylodes 12 parts, Poria 12 parts, Zhigancao 6 parts, Astragalus 10 parts, Shudi 10 parts, Angelica 6 parts, Baiji 9 10 copies of Ejiao, 10 copies of Eucommia ulmoides, 10 copies of discontinuity, 9 dogwoods, 10 medlars, 10 raspberries, 9 parts of Alisma, 2 parts of Tween-801, 2 parts of sodium benzoate, 330 parts of sugar .
- mice (3) Experimental study on the effect of Chinese medicine anti-AIDS ointment on the immune function of mice.
- the test animals were 6-8 weeks of age.
- the mice weighed 18-22 g, male and female. They were randomly divided into three groups. Two groups were the control group and one was the experimental group.
- Two groups were the control group and one was the experimental group.
- Experiments have shown that after taking Chinese medicine against AIDS, it can enhance the non-specific immune function, cellular immunity and blood immune function of mice.
- Myocardial fiber atrophy and few myocardial fiber vacuole degeneration were observed in a small number of rats in the high-dose group. But it can return to normal after 4 weeks. This shows that the Chinese medicine has no obvious toxicity against AIDS. It is safe to use according to the prescribed dosage and treatment course.
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Microbiology (AREA)
- Virology (AREA)
- Cell Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Tropical Medicine & Parasitology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- AIDS & HIV (AREA)
- Dermatology (AREA)
- Biomedical Technology (AREA)
- Developmental Biology & Embryology (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
种抗艾滋病的中药煎赍及其制备方法 发明的技术领域 Anti-AIDS Chinese medicine fried scallion and preparation method thereof
中药抗艾滋病育滋, 又名 "中药生命泉" 及其制法, 属于由植物材料构成 的中药抗艾滋病医用配制品技术领域。 Traditional Chinese medicine anti-AIDS breeding, also known as "Chinese medicine life spring" and its preparation method, belongs to the technical field of traditional Chinese medicine anti-AIDS medical preparations composed of plant materials.
发明的技术背景 Technical background of the invention
目前, 艾滋病已波及全球 1 60多个国家和地区. 在亚洲呈明显上升趋 势。艾滋病是由于 H I V感染所引起的以细胞免疫缺陷为主要表现的自身免疫 性疾病, 其治疗包括: 对抗以 H I V为主的病毒感染和其他条件性病原体感 染、调节免疫机能、治疗恶性病变 (如卡波氏肉瘤、淋巴瘤) 和支持疗法。据 悉目前美国正在研制幵发抗艾滋病的新药不少于 50种, 但是经 FD A批准用 于临床的仅只有叠氮胸苷 ( A Z T ) 、 双脱氧肌苷 (D D I ) 、 双脱氧胸苷 (DDT) 、双脱氧胞苷 (DDC)等. 但是这些药物不能根治艾滋病, 副作 用大, 价格昂贵。 正如在 1993年夏, 于柏林召幵的国际艾滋病大会上有学 者通过长期研究认为. 虽然叠氮胸苷 (AZT) 能暂吋缓解艾滋病的症状, 但 由于很快产生耐药性和明显的骨髓抑制毒性, 故不能延长 H I V感染者和艾滋 病人的生命。鉴此, 近十几年以来, 我国不少学者对中草药和中药复方制剂进 行了免疫病理研究。就其对免疫功能的影响的分类和临床试用效果方面^ — 定的成效。 中草药及其复方制剂的药理作用体现在以下方面: 对抗病毒和某些 机会性感染, 提髙或抑制机体的免疫机能和对免疫机能的影响以及双向调节机 理。 当今, 国内外常用于治疗艾滋病的中药有: 甘草甜素 (即强力宁) 、八味 黄芪片、香茹多糖等。据报道这些中药有抑制艾滋病毒的形成和感染细胞的变 性的作用, 对某些艾滋病症有一定疗效。 从专利文献检索获悉: 在本发明申请 专利之前, 已经有相近的以中药为原料治疗艾滋病的各种中药制剂向中国专利 局提出申请, 例如 《中成药艾滋灵制剂的生产方法》 [CN 8810004 8 A ( 1988 ) 〗; 《防治艾滋病中药方剂的制备方法》 [ C N 1062844 A ( 1992 ) ]; 《一种治疗艾滋病的药物》 [CN 1092661 A ( 19 94 ) ]; 《中草药抗艾滋病制剂》 [CN 1 091 64 1 A ( 1 99'4 ) ] 等。从上述文献所公开的内容可知, 它们系一种抗病毒、增强免疫力和对症治 疗的制剂; 制备方法简单; 服用方便;无明显毒副反应: 且经临床小量试验; 具有抗艾滋病的作用。将本发明技术方案与上述的文件对比可知, 它们的技术 方案不相同. 且本发明的技术方案经过动物试验和临床试验的检验, 从而证明 了中药抗艾滋病青滋设计方案的可行性和有效性。 At present, AIDS has spread to more than 160 countries and regions around the world. It is showing a clear upward trend in Asia. AIDS is an autoimmune disease mainly manifested by cellular immune deficiency caused by HIV infection, and its treatment includes: combating HIV-based virus infection and other conditional pathogen infection, regulating immune function, treating malignant diseases (such as card (Bosch's sarcoma, lymphoma) and supportive therapies. It is reported that no less than 50 new anti-AIDS drugs are currently being developed in the United States, but only azidothymidine (AZT), dideoxyinosine (DDI), dideoxythymidine (DDT) are approved for clinical use by FD A. ), Dideoxycytidine (DDC), etc. However, these drugs cannot cure AIDS, have large side effects and are expensive. As in the summer of 1993, scholars at the International AIDS Conference in Berlin held a long-term study. Although azidothymidine (AZT) can temporarily relieve the symptoms of AIDS, it quickly develops drug resistance and obvious bone marrow. Suppresses toxicity and therefore cannot prolong the lives of people living with HIV and AIDS. In view of this, in the past ten years, many scholars in China have conducted immunopathological research on Chinese herbal medicine and Chinese herbal compound preparations. In terms of its effect on immune function classification and clinical trial effect ^ — determined effectiveness. The pharmacological effects of Chinese herbal medicine and its compound preparations are reflected in the following aspects: fight against viruses and certain opportunistic infections, improve or suppress the body's immune function and its effect on immune function, and the two-way regulation mechanism. At present, the traditional Chinese medicines used to treat AIDS at home and abroad are: glycyrrhizin (ie Qiangli Ning), Bawei astragalus tablets, Xiangru polysaccharides and so on. It is reported that these Chinese medicines have the effect of inhibiting the formation of HIV and the degeneration of infected cells, and have a certain effect on some AIDS. It is learned from the patent literature search: Before the patent application of the present invention, there have been similar applications of various traditional Chinese medicines for treating AIDS with Chinese medicine as raw materials to the China Patent Office, such as "Production Method of Traditional Chinese Medicine Aidling Preparations" [CN 8810004 8 A (1988); "Preparation Method of Traditional Chinese Medicine Prescriptions for the Prevention and Treatment of AIDS" [CN 1062844 A (1992)]; "A Drug for the Treatment of AIDS" [CN 1092661 A (19 94)]; "Traditional Chinese Herbal Anti-AIDS Preparations" [CN 1 091 64 1 A (1 99'4)] and so on. It can be known from the contents disclosed in the above documents that they are an antiviral, immunity-improving and symptomatic preparation; the preparation method is simple; the administration is convenient; there are no obvious toxic side effects: and they have undergone small clinical trials; they have anti-AIDS effects . Comparing the technical scheme of the present invention with the above-mentioned documents, it can be seen that their technical schemes are different. And the technical scheme of the present invention has been tested by animal tests and clinical trials to prove The feasibility and effectiveness of the Chinese medicine anti-AIDS blues design scheme was discussed.
发明的主要内容 The main content of the invention
本发明的目的在于: 为艾滋病患者提供一种疗效高、副作用小、安全可 靠、价格较便宜的中药制剂。 The purpose of the present invention is to provide a Chinese medicine preparation for AIDS patients with high efficacy, small side effects, safety and reliability, and cheap price.
中药抗艾滋病資滋所需给予保护的技术方案如下: 本发明技术方案的基本 设计思想是选择促使 C D 4 和 C D 8 淋巴细胞上升; 对免疫机能有双向调节 作用; 能抗炎、抗病毒和改善机体营养状况的中草药为原料组份. 并根据临床 试用, 研究分析拟定出相应的组份比例及其生产制备工艺流程。按此组份和重 量比例以及工艺流程配制, 即可制备出中药抗艾滋病育滋。 The technical scheme for the protection of Chinese medicine against AIDS is as follows: The basic design idea of the technical scheme of the present invention is to choose to promote the rise of CD 4 and CD 8 lymphocytes; it has two-way regulation of immune function; it can resist inflammation, anti-virus and improve The Chinese herbal medicine of the body's nutritional status is the raw material component. According to clinical trials, research and analysis formulate the corresponding component proportion and its production process. According to this component, weight ratio and technological process, Chinese medicine can be prepared to fight AIDS.
中药抗艾滋病育滋的组份和重量比例如下: 党参 1 2份、 白术 1 2份、茯 苓 1 2份、炙甘草 6份、黄芪 1 0份、熟地 1 0份、 当归 6份、 白芍 9份、阿 胶 10份、杜仲 1 0份、续断 10份、 山茱萸 9份、枸杞 10份、覆盆子 1 0 份、泽泻 9份、吐温 -801 2份、苯甲酸钠 2份、冰糖 330份。 The components and weight ratios of Chinese medicines against AIDS are as follows: Dangshen 12 parts, Atractylodes 12 parts, Poria 12 parts, Zhigancao 6 parts, Astragalus 10 parts, Shudi 10 parts, Angelica 6 parts, Baiji 9 10 copies of Ejiao, 10 copies of Eucommia ulmoides, 10 copies of discontinuity, 9 dogwoods, 10 medlars, 10 raspberries, 9 parts of Alisma, 2 parts of Tween-801, 2 parts of sodium benzoate, 330 parts of sugar .
中药抗艾滋病育滋按以下次序的步骤方法进行制备。 Traditional Chinese medicine anti-AIDS breeding is prepared according to the following steps.
(1 )取党参 1 2份和重量为党参 10倍的 60%的乙醇作溶媒, 使用常 规的渗漉法进行操作。 即将党参置于乙醇中浸渍 24小时后, 再行渗漉, 弃药 渣; 回收乙醇; 提取党参中的有效成份, 并使其浓缩为稠膏. 相对密度为 1.3, 备用。 因为党参中的皂甙、微量元素和氨基酸等有效成份. 既可用 6 0 %乙醇作为溶媒提取又能降低淀粉等杂质的溶出量。 (1) Take 12 parts of Codonopsis and 60% ethanol which is 10 times the weight of Codonopsis as a solvent, and use the normal infiltration method for operation. That is, the ginseng is immersed in ethanol for 24 hours, and then infiltrated, and the drug residue is discarded; the ethanol is recovered; the effective ingredients in the ginseng are extracted and concentrated into a thick paste. The relative density is 1.3, and it is reserved. Because of the active ingredients such as saponin, trace elements and amino acids in Codonopsis, it can be extracted with 60% ethanol as a solvent and can reduce the dissolution of impurities such as starch.
( 2 ) 取阿胶 1 0份. 对其加温至 60°C- 8 0°C, 使之溶化均匀, 备 用。 (2) Take 10 parts of Ejiao. Warm it to 60 ° C-80 ° C to make it melt evenly and set aside.
(3 )取白术 1 2份、 当归 6份、 白芍 9份、泽泻 9份、覆盆子 1 0份, 将它们混合之后, 在 1 00°C-1 20°C的环境下蒸馏 6小时, 提取它们的挥 发油, 实验证明可以提取恽发油总量的 98 %, 再将余下的药渣与水相混合, 在 100°C的环境下煎煮 2小时, 经过滤, 弃药渣, 取药液, 再将药液与挥发 油混合 备用。 (3) Take 12 parts of Atractylodes, 6 parts of Angelica, 9 parts of Amaranth, 9 parts of Alisma, 10 parts of Raspberry, mix them, and distill at 100 ° C-1 20 ° C for 6 hours. Extract their volatile oil. Experiments show that 98% of the total hair oil can be extracted. Then, the remaining residue is mixed with water and cooked at 100 ° C for 2 hours. After filtration, the residue is discarded. Chemical solution, and then mix the chemical solution with volatile oil for later use.
(4 )取熟地 1 0份、 山茱萸 9份、杜仲 1 0份、茯苓 12份、续断 1 0 份、炙甘草 6份、黄芪 1 0份、枸杞 10份。将它们切成 2-3寸长, 以 3-5 目为宜, 用清水洗净, 捞起沥干后. 置于锅中, 加水, 使水面高于药材面 2- 3寸, 上压竹匾. 煮至沸腾. 在维持沸腾状态下, 共煎煮三次, 每次 1小时, 且每次均经过滤, 弃药渣, 取药液. 并将三部份药液合并. 浓縮至稠育状. 使 其相对密度为 1.3. 备用。实验证明. 上述的每次煎煮时间和提取次数是较 合理的。 (4) Take 10 parts of cooked land, 9 parts of dogwood, 10 parts of Eucommia ulmoides, 12 parts of Poria, 10 parts of continuity, 6 parts of Zhigancao, 10 parts of Astragalus and 10 parts of Chinese wolfberry. Cut them into 2-3 inches long, preferably 3-5 mesh, wash them with water, pick them up and drain them. Put them in a pot, add water so that the water surface is 2-3 inches above the medicinal material surface, press the bamboo Plaque. Boil to boiling. While maintaining the boiling state, cook three times in total for 1 hour each time, and filter each time, discard the drug residue, and take the liquid medicine. Combine the three liquid medicines. Concentrate to thick Breeding. Make it a relative density of 1.3. The experiment proves that the above cooking time and extraction times are relatively reasonable.
(5 ) 将浓缩的党参稠青, 溶化均匀的阿胶、 白术、 当归、 白芍、泽泻、 覆盆子的恽发油与药液的混合物, 熟地、 山茱萸、 杜仲、茯苓、 续断、 炙甘 草、黄芪、枸杞的混合稠 ¾P进行混合. 使之均匀。 (5) Dissolve the concentrated Codonopsis thick green, dissolve the homogeneous Ejiao, Atractylodes, Angelica, Angelica, Alisma, Raspberry hair oil and medicinal liquid mixture, sage, dogwood, eucommia ulmoides, Poria cocos, sclerophylla, licorice , Astragalus, wolfberry mixed thick ¾P to mix. Make it even.
( 6 )取冰糖 330份, 加温使之均匀溶化, 备用。 (6) Take 330 parts of rock candy, heat to dissolve it uniformly, and set aside.
( 7) 将党参等 1 5味药构成的稠音与溶化均匀的冰糖混合, 在 60 C - 80 °C的环境下再进行 30分钟的加温处理。 (7) Mix the thick sound of 15 flavors of Dangshen and other medicines with the uniformly dissolved rock sugar, and heat for another 30 minutes at 60 C-80 ° C.
(8 ) 在党参等 1 5味药与冰糖合成的育滋出锅之前 1 5分钟的时刻, 加 入苯甲酸钠 2份, 吐温- 801 2份, 其中吐温 -80以 1.2g/ral的状态加入. 将 它们混合、收 ¾f, 即成为中药抗艾滋病育滋。 其相对密度为 1.3。经筛选实 验结果证明. 选用 2份的苯甲酸钠和吐温 -801 2份作为防腐剂和增溶剂是适 宜的。 (8) Add 15 parts of sodium benzoate and 2 parts of Tween-801 at a time of 15 minutes before the codifying pot of 15 flavor medicines and crystal sugar, such as Codonopsis, and Tween-80 in a state of 1.2g / ral Add. Mix them and collect ¾f, it will become a Chinese medicine to fight AIDS. Its relative density is 1.3. The results of screening experiments prove that it is appropriate to use 2 parts of sodium benzoate and 2 parts of Tween-801 as preservatives and solubilizers.
此外, 中药抗艾滋病資滋应按照企业技术标准进行检测。 In addition, the anti-AIDS drug of Chinese medicine should be tested according to the technical standards of the enterprise.
根据上述工艺过程, 即可绘制出工艺流程图. 如说明书附图所示。 According to the above process, a process flow chart can be drawn. As shown in the accompanying drawings.
中药抗艾滋病膏滋的技术要求如下 ·. The technical requirements of Chinese medicine anti-AIDS ointment are as follows:
( 1 ) 感官要求: 棕褐色, 香甜、微酸. 粘稠适中. 细腻. 无肉眼可见的 杂质和口感无砂。 (1) Sensory requirements: tan, sweet, slightly sour. Moderate stickiness. Fine. No visible impurities and no sand.
( 2 )理化指标 '· (2) Physical and chemical indicators'
水份 < 1 2.56% Moisture <1 2.56%
总糖(以蔗糖汁) < 68 Total sugar (in sucrose juice) <68
脂肪 < 0.4 3 % Fat <0.4 3%
蛋白质 < 1 1.4% Protein <1 1.4%
PH值 4.5-7.0 PH value 4.5-7.0
比重 1.3 Specific gravity 1.3
(3)卫生标准: (3) Sanitary standards:
砷 (以 Asi†mg/kg) 0.5 Arsenic (as Asi † mg / kg) 0.5
铅(以 Pb计 mg/kg) < 1 Lead (mg / kg as Pb) <1
铜 (以 Cuthng/kg) < 1 Copper (in Cuthng / kg) <1
(4)微生物指标: (4) Microbiological indicators:
细菌总数 (·个 /9) 1000 Total bacteria (· pieces / 9) 1000
大肠菌群 (个 /1 00) <30 Coliform group (pcs / 1 00) <30
致病菌 不得检出 按照上述技术方案设计、制备的中药抗艾滋病 滋就是本发明的一种最好实施 例。 No pathogens can be detected The traditional Chinese medicine anti-AIDS designed and prepared according to the above technical scheme is a best embodiment of the present invention.
为了验证本发明所设计的技术方案的可行性和有效性以及它与现有治疗艾 滋病的药物相比所具有的有益效果. 发明人在有关科研、教学单位协作下. 曾 进行了多项实验研究, 现将这些研究项目内容及其结果简述如下: In order to verify the feasibility and effectiveness of the technical scheme designed by the present invention and its beneficial effects compared with existing drugs for treating AIDS. The inventor has carried out a number of experimental studies in collaboration with relevant scientific research and teaching units. The contents of these research projects and their results are briefly described as follows:
( 1 ) 中药抗艾滋病膏滋对 H I V— I ( I型人类免疫缺陷病毒. 即 I型 艾滋病毒) 、 H I v— ll (Π型人类免疫缺陷病毒. 即 II型艾滋病毒) 抑制作 用的研究。其结果证明: 中药抗艾滋病脊滋在体外细胞内对 H I V- I有轻度 抑制作用, 对 H I V— II有明显抑制作用。 (1) Study on the inhibitory effects of Chinese medicine anti-AIDS ointment on H I V—I (type I human immunodeficiency virus. Type I HIV) and H I v—ll (type II human immunodeficiency virus. Type II HIV). The results prove that: Chinese medicine anti-AIDS spinal AIDS has a mild inhibitory effect on H I V-I in vitro and a significant inhibitory effect on H I V-II.
( 2 ) 中药抗艾滋病育滋最低抑菌浓度 (M I C ) 的实验研究。研究结果 证明, 该药物对白色葡萄球菌、链球菌、痢疾杆菌和伤寒扦菌均有抑制作用。 (2) Experimental research on the minimum inhibitory concentration (M I C) of Chinese medicine against AIDS. The results of the study proved that the drug has an inhibitory effect on Staphylococcus albicans, Streptococcus, Shigella and Typhoid bacillus.
( 3 ) 中药抗艾滋病膏滋对小鼠免疫功能影响的实验研究。 受试动物是 6— 8周齡. 体重为 1 8— 22g, 雌雄各半的小鼠. 随机分为三组. 其中两 组为对照组, 一组为实验组。 实验证明:当服用中药抗艾滋病青滋后, 可以增 强小鼠非特异性免疫机能及细胞免疫、血液免疫功能。 (3) Experimental study on the effect of Chinese medicine anti-AIDS ointment on the immune function of mice. The test animals were 6-8 weeks of age. The mice weighed 18-22 g, male and female. They were randomly divided into three groups. Two groups were the control group and one was the experimental group. Experiments have shown that after taking Chinese medicine against AIDS, it can enhance the non-specific immune function, cellular immunity and blood immune function of mice.
(4 ) 中药抗艾滋病 滋急性毒性实验研究。受试动物是体重 18— 22 g小鼠 4 0只, 雌雄各半分为两组, MTD为 1 2 Og/kg. 相当于人临床用量 (1. 2 g/k g ) 的 100倍。观察 7天之后, 两组无一只死亡. 且外观、 行为、活动、摄食等无异常, 未得出 L D 50 , 从而证明急性毒性试验无毒。 (4) Experimental study on the acute toxicity of Chinese medicine against AIDS. The test animals were 40 mice weighing 18-22 g. The males and females were divided into two groups, and the MTD was 12 Og / kg. It was equivalent to 100 times the human clinical dosage (1.2 g / k g). After 7 days of observation, none of the two groups died. And there were no abnormalities in appearance, behavior, activity, feeding, etc., and no L D 50 was obtained, thus proving that the acute toxicity test was non-toxic.
( 5 ) 中药抗艾滋病青滋长期毒性试验。受试动物是 S D大白鼠. 6— 7 - 周龄, 体重 80 ± 1 5g, 雌雄各半. 毎组 7 7只, 设实验组和对照组。给实 验组口服大剂量 (分 3. 75m 1/k g , 6. 5m 1/k g■ 1 3m 1/k 9三种不同剂量进行, 为临床剂量的 2 7倍) 的情况下, 经 1 80天口服毒性 试验, 发现受试动物的体重增长较对照组迟缓、 fl卑脏轻度瘀血; 高剂量组的少 数大 S鼠的心肌纤维萎縮和少数心肌纤维空泡变性。但停药 4周后即可以恢复 正常。 从而说明中药抗艾滋病資滋无明显毒性. 按规定的剂量和疗程使用是安 全的。 (5) Long-term toxicity test of Chinese medicine against HIV / AIDS. The test animals were SD rats, 6-7 weeks old, weighing 80 ± 1 5g, half male and half male. The tadpole group was composed of 7 and 7 animals. The experimental group and the control group were set up. The experimental group was given a large oral dose (in 3.75m 1 / kg, 6. 5m 1 / kg ■ 3m 1 / k 9 three different doses, which is 27 times the clinical dose), after 1 80 days The oral toxicity test found that the weight gain of the tested animals was slower than that of the control group, and the flesh was mildly stagnant. Myocardial fiber atrophy and few myocardial fiber vacuole degeneration were observed in a small number of rats in the high-dose group. But it can return to normal after 4 weeks. This shows that the Chinese medicine has no obvious toxicity against AIDS. It is safe to use according to the prescribed dosage and treatment course.
( 6 ) 中药抗艾滋病胥滋对大鼠垂体一一肾上腺皮质轴作用的实验研究。 受试动物是 Wistar大鼠 50只, 雌雄各半, 体重 1 20 ± 30 g, 中药抗艾滋 病育滋为 2 g/ml 试验证明本药物对大鼠垂体一一肾上腺皮质轴无兴奋和抑制 作用。 (6) Experimental study of the effect of Chinese medicine anti-AIDS on the pituitary-adrenal cortex axis in rats. The test animals were 50 Wistar rats, half male and half male, weighing 1 20 ± 30 g, and the Chinese medicine resisted AIDS was 2 g / ml. The test proved that the drug had no excitatory and inhibitory effects on the rat pituitary-adrenal cortex axis.
在动物实验的基础上进行了临床试验研究。 发明人曾使用本育滋对艾滋病和艾滋病相关综合症患者 2 7例进行治疗, 其中中国籍患者 2 0人, 外国 (缅甸、 泰国) 籍患者 7人. 包括了四个民族。 历时 3个月, 后又跟踪随访一年。治疗结果如下: 经治疗症状和体征得到明显 的改善. 体温恢复正常. 腹泻停止, 皮疹消散或明显减少,机会性感染少、体 重增加、实验指标得到不同程度的改善。在 2 7病例中, 显效者 1 8例 (占 6 6.7%) , 有效者 8例 (占 2 9. 6%) , 一度无效, 病情有反复又未坚持 治疗而死亡者 1例 (占 3 · 7%〉 。 Based on animal experiments, clinical trials were conducted. The inventor has used this to treat 27 patients with AIDS and AIDS-related syndromes, including 20 Chinese patients and 7 foreign (Myanmar, Thai) national patients. Including four ethnic groups. It lasted for 3 months and was followed up for another year. The treatment results are as follows: After treatment, the symptoms and signs are significantly improved. The body temperature returns to normal. Diarrhea stops, the rash dissipates or decreases significantly, less opportunistic infections, weight gain, and experimental indicators are improved to varying degrees. Of the 27 cases, 18 cases were markedly effective (accounting for 6 6.7%), 8 cases were effective (accounting for 2 9.6%), were once ineffective, and one case died repeatedly and did not adhere to treatment (accounting for 3 · 7%>.
以上实践证明: 中药抗艾滋病育滋与现行巿场上所销售的同类药物相比 较, 前者对艾滋病的治疗效果是明显的或比较明显的; 且无副作用; 安全可 靠;价格便宜, 以一个疗程计算. 其价格仅为西药的二十分之一。 The above practice proves that: compared with the similar drugs sold on the market, the traditional Chinese medicine for anti-AIDS breeding has obvious or obvious effects on AIDS; and there are no side effects; safe and reliable; the price is cheap, calculated by one course of treatment Its price is only one-twentieth of that of western medicine.
Claims
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU32517/95A AU3251795A (en) | 1995-05-15 | 1995-08-23 | An anti-aids semifluid extract of traditional chinese medici nes and preparation thereof |
| DE19581937T DE19581937C2 (en) | 1995-05-15 | 1995-08-23 | Anti-AIDS extract from Chinese traditional medicines and its manufacturing process |
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN95104946.1 | 1995-05-15 | ||
| CN95104946 | 1995-05-15 | ||
| CN95108283A CN1056286C (en) | 1995-07-26 | 1995-07-26 | Traditional Chinese medicine ointment for AIDS |
| CN95108283.3 | 1995-07-26 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO1996036345A1 true WO1996036345A1 (en) | 1996-11-21 |
Family
ID=25743713
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/CN1995/000069 Ceased WO1996036345A1 (en) | 1995-05-15 | 1995-08-23 | An anti-aids semifluid extract of traditional chinese medicines and preparation thereof |
Country Status (3)
| Country | Link |
|---|---|
| AU (1) | AU3251795A (en) |
| DE (1) | DE19581937C2 (en) |
| WO (1) | WO1996036345A1 (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103798577A (en) * | 2012-11-15 | 2014-05-21 | 万玉洁 | Vigor-tonifying paste prepared from sea cucumber and ginseng |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103110743B (en) * | 2013-03-08 | 2014-07-23 | 崔合芳 | Traditional Chinese medicine composition for treating or preventing neurasthenia and preparation method thereof |
| CN103599238B (en) * | 2013-10-21 | 2015-08-05 | 张霞 | A kind of Chinese medicine composition being used for the treatment of seborrheic alopecia |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN88100048A (en) * | 1988-01-09 | 1988-10-26 | 李秋宝 | The production method of Chinese patent medicine AIDS spirit (AIDSLIUM) preparation |
| CN1062844A (en) * | 1990-12-29 | 1992-07-22 | 郑有田 | Prevent and treat the preparation method of AIDS Chinese medicinal formulae |
| CN1065209A (en) * | 1992-01-16 | 1992-10-14 | 赵文元 | Medicine for treating aids |
-
1995
- 1995-08-23 DE DE19581937T patent/DE19581937C2/en not_active Expired - Fee Related
- 1995-08-23 AU AU32517/95A patent/AU3251795A/en not_active Abandoned
- 1995-08-23 WO PCT/CN1995/000069 patent/WO1996036345A1/en not_active Ceased
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN88100048A (en) * | 1988-01-09 | 1988-10-26 | 李秋宝 | The production method of Chinese patent medicine AIDS spirit (AIDSLIUM) preparation |
| CN1062844A (en) * | 1990-12-29 | 1992-07-22 | 郑有田 | Prevent and treat the preparation method of AIDS Chinese medicinal formulae |
| CN1065209A (en) * | 1992-01-16 | 1992-10-14 | 赵文元 | Medicine for treating aids |
Non-Patent Citations (4)
| Title |
|---|
| LIU JIWU: "A medicine for treating HIV was found in dehongzhou of yunnan province", MEDICINE NEWS, no. 4, 1994, pages 15 - 16 * |
| THE PHARMACY OF CHINESE TRADITIONAL MEDICAL MATERIALS, CAO, CHUNLING, PUBLISHED BY THE SCIENCE TECHNOLOGY PRESS OF SHANGHAI, pages 170 - 171 * |
| WANG JIE: "The Chinese traditional medical theory for preventing or treating HIV and methods thereof", THE MAGAZINE OF COMBINATION OF CHINESE TRADITIONAL AND WESTERN MEDICINE, vol. 11, no. 7, 1991, pages 430 - 432 * |
| ZHENG CHANGRONG ET AL.: "The development of treating different type of HIV according to Chinese traditional theory", THE CHINESE TRADITIONAL MEDICAL MAGAZINE OF LIAONING, no. 10, 1991, pages 45 - 48 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103798577A (en) * | 2012-11-15 | 2014-05-21 | 万玉洁 | Vigor-tonifying paste prepared from sea cucumber and ginseng |
Also Published As
| Publication number | Publication date |
|---|---|
| AU3251795A (en) | 1996-11-29 |
| DE19581937T1 (en) | 1998-04-16 |
| DE19581937C2 (en) | 2003-06-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN113521232B (en) | A Chinese medicinal composition containing Atractylodis rhizoma | |
| JP2004161732A (en) | Herbal pharmaceutical compositions for the treatment of HIV / AIDS patients | |
| CN118434431A (en) | Traditional Chinese medicine composition and preparation method and application thereof | |
| CN101569739B (en) | Traditional Chinese medicine composition for treating cholecystitis and preparation method thereof | |
| CN1144097A (en) | Longzhusan powder | |
| CN109106887B (en) | Compound Chinese herbal medicine preparation for preventing white diarrhea of native chickens | |
| CN104189349B (en) | Traditional Chinese medicine composition for treating oligomenorrhea | |
| WO1996036345A1 (en) | An anti-aids semifluid extract of traditional chinese medicines and preparation thereof | |
| CN103877483A (en) | Traditional Chinese medicine for treating chronic gastritis and preparation method thereof | |
| CN104257839B (en) | A kind of Chinese medicine composition with hypoglycemic protection blood vessel endothelium effect and preparation method thereof | |
| CN1049128C (en) | Antidiarrheal powder for baby | |
| CN1090183A (en) | Artemisia scoparia and ginseng pellet for mourishing liver and method for production thereof | |
| CN101745093B (en) | A drug for rapid treatment of chronic diarrhea in children | |
| JPH03127736A (en) | Pill preparation of specifically added chinese herbal remedy of cinnamon bark and powdered hoelen and production thereof | |
| CN104840891A (en) | Traditional Chinese medicine preparation used for treating alcoholic cardiomyopathy and preparation method thereof | |
| CN104758676A (en) | Medicine for treating damp-heat in resistance-type epigastric pain | |
| CN111759901B (en) | Traditional Chinese medicine composition for treating functional abdominal pain of children and preparation method thereof | |
| CN100528185C (en) | Chinese medicine capsule for treating AIDS and its preparing method | |
| CN1056286C (en) | Traditional Chinese medicine ointment for AIDS | |
| CN120093871A (en) | Chinese medicinal compound with medicinal and edible properties for treating simple obesity and non-alcoholic fatty liver disease and its application | |
| CN106563076A (en) | Stomach disease treating medicine and production method thereof | |
| CN118750553A (en) | A Yin-nourishing composition, preparation method and application | |
| CN104771705A (en) | Traditional Chinese medicine preparation for treating chronic nephritis | |
| CN105920539A (en) | Medicament for treating foot-and-mouth disease of sheep | |
| CN115282242A (en) | Traditional Chinese medicine composition for treating children mesenteric lymphadenitis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AK | Designated states |
Kind code of ref document: A1 Designated state(s): AM AT AU BB BG BR BY CA CH CN CZ DE DK EE ES FI GB GE HU IS JP KE KG KP KR KZ LK LR LT LU LV MD MG MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TT UA UG US UZ VN |
|
| AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): KE MW SD SZ UG AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG |
|
| DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
| RET | De translation (de og part 6b) |
Ref document number: 19581937 Country of ref document: DE Date of ref document: 19980416 |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 19581937 Country of ref document: DE |
|
| 122 | Ep: pct application non-entry in european phase | ||
| NENP | Non-entry into the national phase |
Ref country code: CA |
|
| WR | Later publication of a revised version of an international search report |